Scottish Chemo-Endocrine Trial D

Not Applicable

Completed

• Conditions: Breast cancer; Cancer; Malignant neoplasm of breast

• Registration Number: ISRCTN43697410
• Lead Sponsor: Scottish Cancer Therapy Network (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2002-08-19
• Study Completion: 2004-06-30
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 2000

Inclusion Criteria

1. Pre- or post-menopausal
2. Histologically confirmed palpable unilateral invasive breast cancer of TNM (Tumour, Node, Metastasis) stages T1-T3, N0-N1 and M0, for whom adjuvant chemotherapy is considered an essential part of initial therapy
3. A bilateral mammography to have been performed within the year prior to randomisation

Exclusion Criteria

1. Patients with in situ carcinoma only, including Paget's disease of the nipple without underlying invasion
2. Presence of distant metastases
3. Patients currently receiving tamoxifen
4. Prior history of other malignancy, other than adequately treated basal or squamous cell carcinoma of skin
5. Other contraindications to treatment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
(Added 05/08/09) Disease free at overall survival

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration